Renew was founded with a simple belief: diabetes and endocrine care should go beyond treating numbers it should help people protect their health for the years ahead. India is facing a growing burden of diabetes, obesity, thyroid disorders and related metabolic complications. The 2025 IDF Diabetes Atlas estimates that 89.8 million Indian adults were living with diabetes in 2024, with around 43% undiagnosed. Meanwhile, new ICMR-INDIAB research shows that metabolic risk can exist even in people who are not considered obese by BMI alone. Renew brings together personalised diabetes management, diabetic foot care, obesity and weight management, thyroid care, and endocrine health to address these conditions comprehensively. Through evidence-based treatment, early risk assessment, preventive care and long-term patient support, we aim to help every patient achieve better metabolic health not simply manage a diagnosis.